Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-10

Clinical Trial Update: Extended Release Naltrexone for Opioid-Dependent Youth [Phase 4]

View source ↗

Summary

Phase 4 trial update on extended release naltrexone for opioid dependence in youth; results completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • extended-release naltrexone (naltrexone)

Snippet

Sponsor: Friends Research Institute, Inc. | Conditions: Drug Dependence | Phase 4 | Status: COMPLETED | Results posted: 2021-11-10